Logo image of MSB

MESABI TRUST (MSB) Stock Fundamental Analysis

USA - NYSE:MSB - US5906721015

31.44 USD
-0.51 (-1.6%)
Last: 9/12/2025, 8:04:00 PM
31.83 USD
+0.39 (+1.24%)
After Hours: 9/12/2025, 8:04:00 PM
Fundamental Rating

7

Overall MSB gets a fundamental rating of 7 out of 10. We evaluated MSB against 156 industry peers in the Metals & Mining industry. MSB has outstanding health and profitabily ratings, belonging to the best of the industry. This is a solid base for any company. MSB has a correct valuation and a medium growth rate. With these ratings, MSB could be worth investigating further for quality investing!.


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

In the past year MSB was profitable.
MSB had a positive operating cash flow in the past year.
MSB had positive earnings in each of the past 5 years.
Each year in the past 5 years MSB had a positive operating cash flow.
MSB Yearly Net Income VS EBIT VS OCF VS FCFMSB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

1.2 Ratios

The Return On Assets of MSB (340.60%) is better than 100.00% of its industry peers.
MSB has a Return On Equity of 476.36%. This is amongst the best in the industry. MSB outperforms 100.00% of its industry peers.
MSB has a better Return On Invested Capital (376.32%) than 100.00% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MSB is significantly above the industry average of 12.92%.
The 3 year average ROIC (152.08%) for MSB is below the current ROIC(376.32%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 340.6%
ROE 476.36%
ROIC 376.32%
ROA(3y)66.81%
ROA(5y)86.02%
ROE(3y)178.92%
ROE(5y)180.43%
ROIC(3y)152.08%
ROIC(5y)151.27%
MSB Yearly ROA, ROE, ROICMSB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500 1K 1.5K

1.3 Margins

The Profit Margin of MSB (96.23%) is better than 100.00% of its industry peers.
In the last couple of years the Profit Margin of MSB has remained more or less at the same level.
MSB's Operating Margin of 96.23% is amongst the best of the industry. MSB outperforms 100.00% of its industry peers.
MSB's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 96.23%
PM (TTM) 96.23%
GM N/A
OM growth 3Y-0.05%
OM growth 5Y0.34%
PM growth 3Y-0.57%
PM growth 5Y0.13%
GM growth 3YN/A
GM growth 5YN/A
MSB Yearly Profit, Operating, Gross MarginsMSB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20 40 60 80

8

2. Health

2.1 Basic Checks

Compared to 1 year ago, MSB has about the same amount of shares outstanding.
MSB has about the same amout of shares outstanding than it did 5 years ago.
MSB has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
MSB Yearly Shares OutstandingMSB Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2M 4M 6M 8M 10M
MSB Yearly Total Debt VS Total AssetsMSB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

2.2 Solvency

MSB has an Altman-Z score of 48.30. This indicates that MSB is financially healthy and has little risk of bankruptcy at the moment.
MSB's Altman-Z score of 48.30 is amongst the best of the industry. MSB outperforms 87.18% of its industry peers.
There is no outstanding debt for MSB. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 48.3
ROIC/WACCN/A
WACCN/A
MSB Yearly LT Debt VS Equity VS FCFMSB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 3.51 indicates that MSB has no problem at all paying its short term obligations.
MSB has a better Current ratio (3.51) than 69.23% of its industry peers.
A Quick Ratio of 3.51 indicates that MSB has no problem at all paying its short term obligations.
MSB has a Quick ratio of 3.51. This is in the better half of the industry: MSB outperforms 73.08% of its industry peers.
Industry RankSector Rank
Current Ratio 3.51
Quick Ratio 3.51
MSB Yearly Current Assets VS Current LiabilitesMSB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M

5

3. Growth

3.1 Past

MSB shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 334.10%, which is quite impressive.
MSB shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 25.43% yearly.
Looking at the last year, MSB shows a very strong growth in Revenue. The Revenue has grown by 256.07%.
Measured over the past years, MSB shows a very strong growth in Revenue. The Revenue has been growing by 25.25% on average per year.
EPS 1Y (TTM)334.1%
EPS 3Y10.7%
EPS 5Y25.43%
EPS Q2Q%2.52%
Revenue 1Y (TTM)256.07%
Revenue growth 3Y11.33%
Revenue growth 5Y25.25%
Sales Q2Q%-24.26%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
MSB Yearly Revenue VS EstimatesMSB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 4.42 indicates a rather cheap valuation of MSB.
Compared to the rest of the industry, the Price/Earnings ratio of MSB indicates a rather cheap valuation: MSB is cheaper than 100.00% of the companies listed in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. MSB is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 4.42
Fwd PE N/A
MSB Price Earnings VS Forward Price EarningsMSB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

MSB's Price/Free Cash Flow ratio is rather cheap when compared to the industry. MSB is cheaper than 98.08% of the companies in the same industry.
Industry RankSector Rank
P/FCF 4.41
EV/EBITDA N/A
MSB Per share dataMSB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

MSB has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0.17
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

MSB has a Yearly Dividend Yield of 20.38%, which is a nice return.
Compared to an average industry Dividend Yield of 2.51, MSB pays a better dividend. On top of this MSB pays more dividend than 100.00% of the companies listed in the same industry.
MSB's Dividend Yield is rather good when compared to the S&P500 average which is at 2.38.
Industry RankSector Rank
Dividend Yield 20.38%

5.2 History

The dividend of MSB decreases each year by -16.67%.
MSB has been paying a dividend for at least 10 years, so it has a reliable track record.
MSB has decreased its dividend in the last 3 years.
Dividend Growth(5Y)-16.67%
Div Incr Years2
Div Non Decr Years2
MSB Yearly Dividends per shareMSB Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6

5.3 Sustainability

MSB pays out 97.32% of its income as dividend. This is not a sustainable payout ratio.
DP97.32%
EPS Next 2YN/A
EPS Next 3YN/A
MSB Yearly Income VS Free CF VS DividendMSB Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
MSB Dividend Payout.MSB Dividend Payout, showing the Payout Ratio.MSB Dividend Payout.PayoutRetained Earnings

MESABI TRUST

NYSE:MSB (9/12/2025, 8:04:00 PM)

After market: 31.83 +0.39 (+1.24%)

31.44

-0.51 (-1.6%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)09-03 2025-09-03
Earnings (Next)12-11 2025-12-11
Inst Owners44.03%
Inst Owner Change3.98%
Ins Owners0.08%
Ins Owner Change0%
Market Cap412.49M
Analysts0
Price TargetN/A
Short Float %3.49%
Short Ratio9.56
Dividend
Industry RankSector Rank
Dividend Yield 20.38%
Yearly Dividend1.35
Dividend Growth(5Y)-16.67%
DP97.32%
Div Incr Years2
Div Non Decr Years2
Ex-Date07-30 2025-07-30 (0.12)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 4.42
Fwd PE N/A
P/S 4.25
P/FCF 4.41
P/OCF 4.41
P/B 21.03
P/tB 21.03
EV/EBITDA N/A
EPS(TTM)7.12
EY22.65%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)7.13
FCFY22.67%
OCF(TTM)7.13
OCFY22.67%
SpS7.4
BVpS1.49
TBVpS1.49
PEG (NY)N/A
PEG (5Y)0.17
Profitability
Industry RankSector Rank
ROA 340.6%
ROE 476.36%
ROCE 476.36%
ROIC 376.32%
ROICexc N/A
ROICexgc N/A
OM 96.23%
PM (TTM) 96.23%
GM N/A
FCFM 96.33%
ROA(3y)66.81%
ROA(5y)86.02%
ROE(3y)178.92%
ROE(5y)180.43%
ROIC(3y)152.08%
ROIC(5y)151.27%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)192.5%
ROCE(5y)191.48%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-0.05%
OM growth 5Y0.34%
PM growth 3Y-0.57%
PM growth 5Y0.13%
GM growth 3YN/A
GM growth 5YN/A
F-Score7
Asset Turnover3.54
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion N/A
Profit Quality 100.1%
Current Ratio 3.51
Quick Ratio 3.51
Altman-Z 48.3
F-Score7
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)146.22%
Profit Quality(5y)123.79%
High Growth Momentum
Growth
EPS 1Y (TTM)334.1%
EPS 3Y10.7%
EPS 5Y25.43%
EPS Q2Q%2.52%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)256.07%
Revenue growth 3Y11.33%
Revenue growth 5Y25.25%
Sales Q2Q%-24.26%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y335.66%
EBIT growth 3Y11.27%
EBIT growth 5Y25.67%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y95521.2%
FCF growth 3Y14.34%
FCF growth 5Y22.12%
OCF growth 1Y95521.2%
OCF growth 3Y14.34%
OCF growth 5Y22.12%